Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
-
14.12.2021 - 15.12.2021  Online
Time: 8:30 am - 6:15 pm
 
Temi della conferenza
As investment in rare neurodevelopmental disorders is surging, there has never been a better time to unite all the key stakeholders across this fast-evolving community.

The inaugural Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups paving the way towards symptomatic and successful disease modifying treatments.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/867375-3?pid=4832

Speakers: Allyson Berent Chief Operating Officer | FAST GeneTx | Biotherapeutics Chief Scientific Officer, Anish Bhatnagar Chief Executive Officer Soleno Therapeutics and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/867375-2?pid=4832
Ms. Stephanie Nketia
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference Only - Drug Developer: USD 2099.00, Conference Only - Academic: USD 1899.00, Conference Only - Service Provider: USD 2599.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinSwiss Tropical and Public Health InstituteÖsterreichische Akademie der ÄrzteÖsterreichische Gesellschaft für Public HealthCharité International AcademyCenter of ExcellenceHilfswerk AustriaOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation